Завершено
Фаза II–III
Россия
NC-503 (Anti-amyloidotic (AA) Agent) · Bellus Health Inc. - a GSK company
A Phase II/III Study of the Safety and Efficacy of NC-503 in Patients Suffering From Secondary (AA) Amyloidosis